Netherlands· NL-08574bec9f17

Febuxostat Viatris 120 mg, filmomhulde tabletten

A febuxostat product containing febuxostat, registered in Netherlands by Viatris Limited. The same ATC class is registered in 19 of our 19 countries.

ATC M04AA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about febuxostatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Febuxostat is registered in 19 of 19 countries.

Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search febuxostat products by name

Febuxostat · ATC M04AA03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of febuxostat costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Febuxostat · price per daily dose (80 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.89
IT Italy$0.69
ES Spain$0.54
FR France$0.34

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FEBUXOSTAT
Manufacturer: Viatris Limited
Country: Netherlands (NL)
ATC code: M04AA03
ATC class: Febuxostat
Defined daily dose: 80 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/17/1194

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for febuxostat.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check febuxostat against other medicines How interaction checks work

Febuxostat · interactions on record

25 records

6 severe
19 moderate

Most severe, free to view

MercaptopurineL01BB02severe
LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Febuxostat in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All febuxostat products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Feburo, Febuxostat +pharma
Belgium · Feburik, Febuxostat Ab
Bulgaria · Адара, Адара 80 Mg Филмирани Таблетки
Cyprus · Febuxostat Genepharm, Urichofeb
Czechia · Febuxostat Sandoz
Germany · Febuxodor, Febuxostat 1 A Pharma
Denmark · Febuxostat Accord, Febuxostat Teva
Estonia · Druniler, Febuxostat Alembic
Spain · Febuxostat Aurovitas, Febuxostat Cinfa
Finland · Febuxostat Accord
France · Febuxostat Accord, Febuxostat Almus
United Kingdom (Northern Ireland) · Elstabya, Febuxostat
Greece · Buxodem, Febuxostat Genepharm
Croatia · Abuxar, Febuksostat
Hungary · Denofix, Doluric
Ireland · Febuxostat Clonmel, Febuxostat Rowa
Iceland · Adenuric, Febuxostat Krka
Italy · Alphabux, Arbux
Liechtenstein · Adenuric, Febuxostat Viatris
Lithuania · Druniler, Febuxostat Teva
Luxembourg · Feburik, Febuxostat
Latvia · Denofix, Druniler
Malta · Febuxostat Pharos
Norway · Adenuric, Febuxostat Krka
Poland · Denofix, Febuxostat Aurovitas
Portugal · Bluesar, Febuxostate Aristo
Sweden · Feburo
Slovenia · Abuxar
Slovakia · Febuxostat Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f3a86397-3bfe-46a6-bb0f-b26793eebebe
GET /v1/drugs/f3a86397-3bfe-46a6-bb0f-b26793eebebe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/febuxostat-viatris-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Febuxostat",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp119313",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSPOVIDON (E 1202)",
    "ETHYLCELLULOSE (E 462)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE, GEHYDRATEERD (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "FEBUXOSTAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2017/06/15",
  "procedure_number": "EMEA/H/C/004374",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1194",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about febuxostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console